Furthermore, SGLT2 inhibitors’ diuretic effects [256] and GLP-1RAs’ impact on cardiac hypertrophy [257] reduce atrial wall stress, addressing mechanical drivers of atrial remodeling. Here, SLC5A2 is linked to cardiac hypertrophy.